VITURA HEALTH LIMITED (VIT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

VIT - VITURA HEALTH LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.06
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.32

25 Sep
2023

0.005

OPEN

$0.32

1.59%

HIGH

$0.33

48,831

LOW

$0.32

TARGET
$0.70 118.8% upside
Franking for last dividend paid out: 100%
FNARENA'S MARKET CONSENSUS FORECASTS
VIT: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 2.5 3.0 xxx
DPS (cps) xxx 1.0 1.0 xxx
EPS Growth xxx 99.2% 20.5% xxx
DPS Growth xxx 0.0% 0.0% xxx
PE Ratio xxx N/A 10.7 xxx
Dividend Yield xxx N/A 3.1% xxx
Div Pay Ratio(%) xxx 40.2% 33.3% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.17

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 1c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx2.5
DPS All xxxxxxxxxxxxxxx1.0
Sales/Revenue xxxxxxxxxxxxxxx117.3 M
Book Value Per Share xxxxxxxxxxxxxxx6.3
Net Operating Cash Flow xxxxxxxxxxxxxxx9.7 M
Net Profit Margin xxxxxxxxxxxxxxx11.77 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx45.22 %
Return on Invested Capital xxxxxxxxxxxxxxx41.41 %
Return on Assets xxxxxxxxxxxxxxx30.77 %
Return on Equity xxxxxxxxxxxxxxx45.22 %
Return on Total Capital xxxxxxxxxxxxxxx59.02 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx3.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx19 M
Price To Book Value xxxxxxxxxxxxxxx8.19

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.79 %
Cost of Goods Sold xxxxxxxxxxxxxxx91 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx6 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

19/09/2023

1

Buy

$0.70

118.75%

Bell Potter notes prescribing activity has surged in August. SAS-B applications, mostly used by new prescribers of medicinal cannabis, in August totalled 15,400 applications, significantly ahead of previous monthly averages.

The Authorised Prescriber path, used by clinicians with greater prescribing experience, was also significantly higher during the month, at 2300 applications.

While there are an increasing number of smaller distributors in the segment, the broker notes Vitura Health has significant market share and is well-positioned to capture industry growth.

The broader integration of CanView 2.0 among prescribers will also be critical to sustaining growth in FY24. Buy rating and $0.70 target unchanged.

FORECAST
Bell Potter forecasts a full year FY24 dividend of 1.00 cents and EPS of 3.00 cents.
Bell Potter forecasts a full year FY25 dividend of 1.00 cents and EPS of 3.60 cents.
Access Stockbroker Research History >

VIT STOCK CHART

FNArena News on VIT

1
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia
2
Breaking Boundaries: Medical Psychedelics

Aug 21 2023 - Small Caps
3
Australian Broker Call *Extra* Edition – Jul 03, 2023

Jul 03 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Jun 07, 2023

Jun 07 2023 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Feb 22, 2023

Feb 22 2023 - Daily Market Reports